In recent years, it has been shown that the alterations in PI3K/AKT signaling pathway components are frequent in human cancers (Fresno Vara et al., 2004) and account for approximately 88% of patients with GBM (Cancer Genome Atlas Research Network, 2008). The gene discussed is AKT1; the disease is glioblastoma.